Targeting kidney mesangium by nanoparticles of defined size. - Wikidata - awgldk - TriplyDB

Targeting kidney mesangium by nanoparticles of defined size.

Targeting kidney mesangium by nanoparticles of defined size.

http://www.wikidata.org/entity/Q34835611

about

Critical questions in development of targeted nanoparticle therapeutics Emerging research and clinical development trends of liposome and lipid nanoparticle drug delivery systems Mesoscale nanoparticles selectively target the renal proximal tubule epithelium Mesenchymal Stem Cells as Therapeutic Candidates for Halting the Progression of Diabetic Nephropathy Biocompatibility of ferritin-based nanoparticles as targeted MRI contrast agents.Construction and validation of nano gold tripods for molecular imaging of living subjects.Three-dimensional optoacoustic imaging as a new noninvasive technique to study long-term biodistribution of optical contrast agents in small animal models.Passing through the renal clearance barrier: toward ultrasmall sizes with stable ligands for potential clinical applications.Au nanomatryoshkas as efficient near-infrared photothermal transducers for cancer treatment: benchmarking against nanoshells Surface functionalization of nanoparticles for nanomedicine.Megalin-mediated specific uptake of chitosan/siRNA nanoparticles in mouse kidney proximal tubule epithelial cells enables AQP1 gene silencing.Transcytosis and brain uptake of transferrin-containing nanoparticles by tuning avidity to transferrin receptor.Transferrin coated nanoparticles: study of the bionano interface in human plasma.H-ferritin-nanocaged doxorubicin nanoparticles specifically target and kill tumors with a single-dose injection.Investigating the optimal size of anticancer nanomedicine.Decationized polyplexes as stable and safe carrier systems for improved biodistribution in systemic gene therapy A comparative study of hollow copper sulfide nanoparticles and hollow gold nanospheres on degradability and toxicity.siRNA delivery to the glomerular mesangium using polycationic cyclodextrin nanoparticles containing siRNA Clinical translation of an ultrasmall inorganic optical-PET imaging nanoparticle probe.Polycation-siRNA nanoparticles can disassemble at the kidney glomerular basement membrane.Enhancing Pharmacokinetics, Tumor Accumulation, and Antitumor Efficacy by Elastin-Like Polypeptide Fusion of Interferon Alpha.Rationally designed oxaliplatin-nanoparticle for enhanced antitumor efficacy Kidney-targeted drug delivery systems.Human anti-α3(IV)NC1 antibody drug conjugates target glomeruli to resolve nephritis.Structural and oxidative changes in the kidney of crucian carp induced by silicon-based quantum dots.Store-Operated Ca2+ Channels in Mesangial Cells Inhibit Matrix Protein Expression.Challenges and opportunities in the advancement of nanomedicines.PEGylation as a strategy for improving nanoparticle-based drug and gene delivery A computational model of flow and species transport in the mesangium.Intraoperative mapping of sentinel lymph node metastases using a clinically translated ultrasmall silica nanoparticle Biofunctionalization of Large Gold Nanorods Realizes Ultrahigh-Sensitivity Optical Imaging Agents.Applications of nanoparticles in the detection and treatment of kidney diseases Nanoparticles as computed tomography contrast agents: current status and future perspectives.Peptide targeted lipid nanoparticles for anticancer drug delivery.Perturbation of physiological systems by nanoparticles.In vitro study of the interaction of heregulin-functionalized magnetic-optical nanorods with MCF7 and MDA-MB-231 cells.Renal allograft fibrosis: biology and therapeutic targets.Role of polymer-drug conjugates in organ-specific delivery systems.Current progress in nanotechnology applications for diagnosis and treatment of kidney diseases.Biodegradable nanoparticles for improved kidney bioavailability of rhein: preparation, characterization, plasma, and kidney pharmacokinetics.

P2860

Q26751896-CD366102-BF9D-43FD-9874-3BE5E4C12738 Q26996159-5C58CEA3-A9B2-4C13-97F5-C3A2D33F8301 Q27335127-AD1E421A-C4BF-40EF-B995-EBDE3D869A25 Q28354224-E01A03D4-4489-4664-9A59-11E5FCE7631D Q30276990-97C56F51-F18D-4BE8-A049-B4FA830C0896 Q30419446-6C5B57AD-BB2F-49F5-9042-0DCBF95FA4FA Q30453496-68F8036D-95EF-44FD-9B99-BD08D44EE703 Q33559267-8B71825D-1B83-4B10-BEF4-CCD1289E9012 Q33824874-84700C6E-24CD-413B-B227-A99E42CB07A2 Q33915941-38EDE5EC-2634-45F5-BDC9-60F83D7B824A Q34080235-11FA98BD-C08F-40FC-A956-9481783F8274 Q34343298-ED6248E2-7AFB-4AAB-8DD4-4F121ECFFA22 Q34351046-8C22A889-0FF2-45CF-9D23-618895FAA8E7 Q34383748-14043A3F-AEE5-4824-A5F9-336B792F4BB3 Q34442139-6F830C9A-8ED9-49FD-AA68-E24F66FBCCC1 Q34626943-968D2FDD-39EB-4350-82A5-8C7E85D99042 Q34992848-0CD9CE8D-5587-49C2-862B-0EC7ED5A717E Q35224125-3476B446-1C36-4B81-A66B-F2E5998845D3 Q35590083-5B8F91D1-B24B-46D2-9107-3123CA797345 Q35778918-51A23413-CE69-4E0A-971D-EEFC874297BA Q35805537-515AF74E-B2B7-4CC0-A0EE-3E66A0937A7B Q36070256-24A581D4-1D7F-4A5D-BA81-B5E5AB7114FB Q36111953-3B5D64C7-A400-473C-A144-6BFD8DCBA553 Q36174495-7B291438-2760-4C68-84BE-E633798B373B Q36202455-E8C6B708-F170-45DE-89E1-2C8B8E2C8D84 Q36223317-5B177C3A-FAFC-4799-B13A-B7A6D301F584 Q36417295-89FBF6AC-49C9-4790-82D5-DE1FF7490973 Q36703361-228F22F6-1AC1-47D6-A14D-EA64C77A2880 Q36955339-C8E97355-9575-44D3-A168-2C6C5B80EC7B Q36994123-67E1ED10-69A9-4379-A5E1-E2AD8F90A3DD Q37131221-6344ECCB-8829-4320-AF94-C0E6D310C448 Q37298541-08F485D0-9348-4322-AC79-9459CEB14762 Q37984484-F758CD7E-6192-4387-AA81-7AF6A159A702 Q38016810-9CC9D698-751C-4256-BF61-0EDBF552A7DE Q38197488-B7514060-44C3-4701-82B9-359FFECAF078 Q38255361-88E50682-10AA-41BF-847C-BD86A6A99F93 Q38359455-24525784-3686-40D9-ABBE-C350D602C829 Q38365556-A7A6675F-76B6-4600-9300-F9DA44B166AD Q38539866-369FFACF-0FF6-4F74-B225-7CCB7ED82B09 Q38686516-50740C4A-07E4-4D10-9748-0C02E45801C3

P2860

Targeting kidney mesangium by nanoparticles of defined size.

http://www.wikidata.org/entity/Q34835611

description

2011 nî lūn-bûn

@nan

2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Targeting kidney mesangium by nanoparticles of defined size.

@ast

Targeting kidney mesangium by nanoparticles of defined size.

@en

Targeting kidney mesangium by nanoparticles of defined size.

@nl

type

label

Targeting kidney mesangium by nanoparticles of defined size.

@ast

Targeting kidney mesangium by nanoparticles of defined size.

@en

Targeting kidney mesangium by nanoparticles of defined size.

@nl

prefLabel

Targeting kidney mesangium by nanoparticles of defined size.

@ast

Targeting kidney mesangium by nanoparticles of defined size.

@en

Targeting kidney mesangium by nanoparticles of defined size.

@nl

P1433

Q34835611-5CFF8C4C-06B2-4617-828E-AE26FA1B1C12

P1476

Q34835611-0EDFBF90-D615-4DE8-959B-DABED326BC47

P2093

Q34835611-4879335F-B01B-4AD3-A462-0945AE1915E3

Q34835611-77429B12-8D49-4BF8-896E-D094A071060C

Q34835611-83FF7169-32DD-4149-BD66-ABDE90511C02

Q34835611-A9D00E6C-9324-477D-B541-10256DF1BDA7

P2860

Q34835611-0E952721-8CA6-4F2D-A5B4-63DD3D54426A

Q34835611-2BC1AE91-A6C8-416B-B8CF-D26FE9C1E5A3

Q34835611-2ED3758E-1A2E-454A-9799-10EF9DB1CC07

Q34835611-3067E56A-79CB-4F1A-83EF-46C1E823B5F8

Q34835611-5A618310-AFA0-4B65-8A7B-58CAF641E611

Q34835611-6B739205-F5BC-4A8A-99C1-6655CC4528B6

Q34835611-75316901-B426-4422-8455-1FAF98081921

Q34835611-7E1F6D30-7DA1-44FD-8B30-40D2B9B8DBFD

Q34835611-81288BAD-4C42-4EF6-8428-7D4AD4DAE001

Q34835611-83B38D52-79D8-4A71-9CF4-FC6A70348AD8

P304

Q34835611-5E4B6532-109E-4340-98EB-FE886821AE4B

P31

Q34835611-17E32445-8C26-4E06-9854-2DBE225ACB45

P356

Q34835611-28D96D63-1608-4F5B-A054-C2DB64D9E45E

P407

Q34835611-C5D91F63-6BF3-4BEB-B475-BAE0028B35A0

P433

Q34835611-9D3D1585-069C-43E7-9D10-D9D698BF6719

P478

Q34835611-C6EEBEB0-2EF5-46E6-BEAF-E6403A0CEF65

P577

Q34835611-C3F7D147-AF00-4FC7-BA84-16A150D1137D

P5875

Q34835611-ACD06B39-C05E-47A4-BA43-EC510F6D17E3

P698

Q34835611-CC13C512-6A16-4405-AE43-CC0B35C8F205

P921

Q34835611-BE3FFBA9-FA2B-45D9-A065-1353A8A1E506

P932

Q34835611-3F4B3125-FE1B-4151-AC12-35787ECBD8A8

P356

PNAS.1103573108

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Targeting kidney mesangium by nanoparticles of defined size.

@en

P2093

Chung Hang J Choi

http://www.w3.org/2001/XMLSchema#string

Jonathan E Zuckerman

http://www.w3.org/2001/XMLSchema#string

Mark E Davis

http://www.w3.org/2001/XMLSchema#string

Paul Webster

http://www.w3.org/2001/XMLSchema#string

P2860

Nanoparticle inhalation augments particle-dependent systemic microvascular dysfunction

Renal clearance of quantum dots.

Ultrafine particles and platelet activation in patients with coronary heart disease--results from a prospective panel study

Nanoparticle therapeutics: an emerging treatment modality for cancer

Nanocarriers as an emerging platform for cancer therapy

Tissue- and organ-selective biodistribution of NIR fluorescent quantum dots.

An effective targeted nanoglobular manganese(II) chelate conjugate for magnetic resonance molecular imaging of tumor extracellular matrix

Impact of tumor-specific targeting on the biodistribution and efficacy of siRNA nanoparticles measured by multimodality in vivo imaging

The mesangial phagocyte and its regulation of contractile cell biology.

Kupffer cells are central in the removal of nanoparticles from the organism.

P304

6656-6661

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.1103573108

http://www.w3.org/2001/XMLSchema#string

P407

P433

16

http://www.w3.org/2001/XMLSchema#string

P478

108

http://www.w3.org/2001/XMLSchema#string

P577

2011-04-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

50999588

http://www.w3.org/2001/XMLSchema#string

P698

21464325

http://www.w3.org/2001/XMLSchema#string

P921

P932

3080986

http://www.w3.org/2001/XMLSchema#string